These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9091578)

  • 1. Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing.
    Legge KL; Min B; Potter NT; Zaghouani H
    J Exp Med; 1997 Mar; 185(6):1043-53. PubMed ID: 9091578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR agonist and antagonist exert in vivo cross-regulation when presented on Igs.
    Legge KL; Min B; Cestra AE; Pack CD; Zaghouani H
    J Immunol; 1998 Jul; 161(1):106-11. PubMed ID: 9647213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-modal antigen specific therapy for autoimmunity.
    Legge KL; Bell JJ; Li L; Gregg R; Caprio JC; Zaghouani H
    Int Rev Immunol; 2001 Oct; 20(5):593-611. PubMed ID: 11890614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis.
    Bell JJ; Divekar RD; Ellis JS; Cascio JA; Haymaker CL; Jain R; Tartar DM; Hoeman CM; Hardaway JC; Zaghouani H
    J Immunol; 2008 Feb; 180(3):1508-16. PubMed ID: 18209046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
    Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H
    J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens.
    Nicholson LB; Murtaza A; Hafler BP; Sette A; Kuchroo VK
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9279-84. PubMed ID: 9256473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon gamma-mediated splenic anergy.
    Min B; Legge KL; Pack C; Zaghouani H
    J Exp Med; 1998 Dec; 188(11):2007-17. PubMed ID: 9841915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal exposure to antigen primes the immune system to develop responses in various lymphoid organs and promotes bystander regulation of diverse T cell specificities.
    Pack CD; Cestra AE; Min B; Legge KL; Li L; Caprio-Young JC; Bell JJ; Gregg RK; Zaghouani H
    J Immunol; 2001 Oct; 167(8):4187-95. PubMed ID: 11591739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis.
    Legge KL; Min B; Bell JJ; Caprio JC; Li L; Gregg RK; Zaghouani H
    J Exp Med; 2000 Jun; 191(12):2039-52. PubMed ID: 10859329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential control of neonatal tolerance by antigen dose versus extended exposure and adjuvant.
    Min B; Legge KL; Caprio JC; Li L; Gregg R; Zaghouani H
    Cell Immunol; 2000 Feb; 200(1):45-55. PubMed ID: 10716882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal exposure to antigen induces a defective CD40 ligand expression that undermines both IL-12 production by APC and IL-2 receptor up-regulation on splenic T cells and perpetuates IFN-gamma-dependent T cell anergy.
    Min B; Legge KL; Bell JJ; Gregg RK; Li L; Caprio JC; Zaghouani H
    J Immunol; 2001 May; 166(9):5594-603. PubMed ID: 11313399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire.
    Kuchroo VK; Greer JM; Kaul D; Ishioka G; Franco A; Sette A; Sobel RA; Lees MB
    J Immunol; 1994 Oct; 153(7):3326-36. PubMed ID: 7522258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
    Kobayashi N; Kobayashi H; Gu L; Malefyt T; Siahaan TJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):879-86. PubMed ID: 17522343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. neonatally primed lymph node, but not splenic T cells, display a Gly-Gly motif within the TCR beta-chain complementarity-determining region 3 that controls affinity and may affect lymphoid organ retention.
    Caprio-Young JC; Bell JJ; Lee HH; Ellis J; Nast D; Sayler G; Min B; Zaghouani H
    J Immunol; 2006 Jan; 176(1):357-64. PubMed ID: 16365428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Break of neonatal Th1 tolerance and exacerbation of experimental allergic encephalomyelitis by interference with B7 costimulation.
    Bell JJ; Min B; Gregg RK; Lee HH; Zaghouani H
    J Immunol; 2003 Aug; 171(4):1801-8. PubMed ID: 12902480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses.
    Teitelbaum D; Fridkis-Hareli M; Arnon R; Sela M
    J Neuroimmunol; 1996 Feb; 64(2):209-17. PubMed ID: 8632064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.
    Kuchroo VK; Anderson AC; Waldner H; Munder M; Bettelli E; Nicholson LB
    Annu Rev Immunol; 2002; 20():101-23. PubMed ID: 11861599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein.
    Das MP; Nicholson LB; Greer JM; Kuchroo VK
    J Exp Med; 1997 Sep; 186(6):867-76. PubMed ID: 9294141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
    Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
    J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.